Late results of treatment and quality of life in women after pelvic exenteration
https://doi.org/10.17650/1726-9776-2016-12-1-36-41
Abstract
Objective: to study the late results and quality of life in women after pelvic exenteration.
Subjects and methods. The late results of surgery and quality of life were studied using the SF-36 questionnaire in 45 women with bladder cancer and in 47 with cervical cancer at follow-ups of 3-104 months (median 51 months) after pelvic exenteration.
Results. The five-year overall and relapse-free survival rates were 60.9±15.8 and 55.4±12.6%, respectively. All quality of life indicators virtually improved as compared to preoperative data.
Conclusion. Pelvic exenteration at a reference center allows patients to achieve rather high survival rates and quality of life.
About the Authors
O. B. Loran
Russian Medical Academy of Postgraduate Education;
S.P. Botkin City Clinical Hospital
Russian Federation
Russian Federation
Department of Urology and Surgical Andrology,
5, Second Botkinsky Passage, Build. 16, Moscow 125284
A. V. Seregin
Russian Medical Academy of Postgraduate Education;
S.P. Botkin City Clinical Hospital
Russian Federation
Russian Federation
Department of Urology and Surgical Andrology,
5, Second Botkinsky Passage, Build. 16, Moscow 125284
Z. A. Dovlatov
S.P. Botkin City Clinical Hospital
Russian Federation
5, Second Botkinsky Passage, Build. 16, Moscow 125284
Russian Federation
5, Second Botkinsky Passage, Build. 16, Moscow 125284
References
1. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2015. 250 с. [Malignant tumors in Russia in 2013 (morbidity and fatality). Ed. by А.D. Kaprin, V.V. Starinsky, G.V. Petrova. М., 2015. 250 с. (In Russ.)].
2. Состояние онкологической помощи населению России в 2013 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2014. 235 с. [Status of cancer care facilities, provided to the population of Russia in 2013. Ed. by А.D. Kaprin, V.V. Starinsky, G.V. Petrova. М., 2015. (In Russ.)].
3. Косенко И.А., Матылевич О.П. Экзентерация таза у больных раком шейки матки: обзор литературы. Онкологический журнал 2008;2(4):82–9. [Коsenkо I.А., Маtylevich О.P. Pelvis exenteration at patients with cervical cancer: literature review. Onkologicheskiy zhurnal = Оncologic Magazine 2008;2(4): 82–9. (In Russ.)].
4. Diver E.J., Rauh-Hain J.A., Del Carmen M.G. Total pelvic exenteration for gynecologic malignancies. Int J Surg Oncol 2012. URL:
5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376473 (Дата обращения: 20.02.2015).
6. Dresen R., Gosens M., Martijn H. et al. Radical resection after IORT-containing multimodality treatment is the most important determinant of outcome in patients treated for LRRC. Ann Surg Oncol 2008;15(7):1937–47.
7. Ferenschild F., Vermaas M., Verhoef C. et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009; 33(7):1502–8.
8. Austin K.K., Young J.M., Solomon M.J. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum 2010;53(8):1121–6.
9. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240(2):205–13.
10. Yoo H.J., Lim M.C., Seo S.S. et al. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea. J Gynecol Oncol 2012;23(4):242–50.
11. Ramamurthy R., Duraipandian A. Morbidity and outcome of pelvic exenteration in locally advanced pelvic malignancies. Indian J Surg Oncol 2012;3(3):231–5.
12. Kim J. Pelvic exenteration: surgical approaches. J Korean Soc Coloproctol 2012;28(6):286–93.
13. Goldberg G.L., Sukumvanich P., Einstein M.H. et al. Total pelvic exenteration: the Albert Einstein College of Medicine/ Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol 2006;101(2):261–8.
14. Ishiguro S., Akasu T., Fujita S. et al. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Surgery 2009:145(2): 189–95.
15. Матылевич О.П., Косенко И.А., Красный С.А. и др. Ближайшие результаты экзентерации таза у больных раком шейки матки. Онкологический журнал 2010;4(1):22–7. [Маtylevich О.P., Kosenkо I.А., Krasny S.А. et al. Recent results of pelvis exenteratopn and patients with cervical cancer. Onkologicheskiy zhurnal = Оncologic Magazine 2010;4(1):22–7. (In Russ.)].
16. Дронов А.И., Крючина Е.А., Горлач А.И., Добуш Р.Д. Экзентерация таза в лечении первичных и рецидивных злокачественных опухолей. Шпитальна хiрургiя 2013;1:111–3. [Dronov А.I., Kruchinа Е.А., Gorlach А.I., Dobush R.D. Pelvis exenteration in the treatment of initial and recurrent malignant tumors. Шпитальна хiрургiя 2013;1:111–3. (In Russ.)].
Review
For citations:
Loran O.B., Seregin A.V., Dovlatov Z.A. Late results of treatment and quality of life in women after pelvic exenteration. Cancer Urology. 2016;12(1):36-41. https://doi.org/10.17650/1726-9776-2016-12-1-36-41
Views:
1130
Email this article 